Initial Approach for a Patient Presenting with an Inguinal Mass

Clinical Assessment

• The American College of Radiology recommends a thorough clinical examination followed by ultrasound imaging to establish the diagnosis before determining appropriate management for a patient with an inguinal mass 1
• A detailed examination of the inguinal mass should document size and dimensions of the mass, as recommended by the American College of Radiology 1
• The National Comprehensive Cancer Network suggests assessing the mobility or fixation of the mass, as well as its relationship to surrounding structures, such as skin and Cooper ligaments 2

Diagnostic Imaging

• High-frequency ultrasound (>10 MHz) is the first-line imaging modality for evaluating an inguinal mass, according to the American College of Radiology and European Urology 1, 3
• Ultrasound helps differentiate between inguinal hernia, lymphadenopathy, testicular masses, and vascular abnormalities, as noted by the National Comprehensive Cancer Network and European Urology 2, 3
• The American College of Radiology recommends considering MRI when ultrasound findings are inconclusive 1
• The National Comprehensive Cancer Network suggests a CT scan of the abdomen and pelvis when metastatic disease is suspected or evaluation of pelvic or retroperitoneal lymph nodes is needed 4

Specific Diagnostic Considerations

• The National Comprehensive Cancer Network recommends evaluating risk factors for penile cancer, including history of HPV infection, HIV status, poor hygiene, tobacco use, and presence of penile lesions, in patients with inguinal lymphadenopathy 5, 6
• Fine-needle aspiration cytology (FNAC) should be performed for palpable nodes, and sentinel node biopsy should be considered for high-risk patients, as recommended by the Annals of Oncology 7
• For suspected testicular mass, the European Urology guidelines recommend performing testicular examination and checking serum tumor markers (AFP, hCG, LDH) 3

Management Algorithm

• The National Comprehensive Cancer Network suggests evaluating for primary malignancy and considering FNAC or excisional biopsy for firm, fixed lymphadenopathy 2, 6, 7, 8

Pitfalls to Avoid

• The Annals of Oncology warns against assuming all inguinal masses are hernias, as up to 50% of palpable inguinal nodes may be enlarged due to inflammatory changes rather than malignancy 7
• The National Comprehensive Cancer Network advises against overlooking the possibility of metastatic disease in patients with unexplained lymphadenopathy 4

Inguinal Mass Evaluation

Essential Mass Characteristics to Document

• The National Comprehensive Cancer Network recommends documenting the physical properties of the mass, including diameter, consistency, reducibility, and tenderness, as well as location specificity and relationship to surrounding structures 9, 10
• The mass characteristics, such as size, mobility, and fixation to surrounding structures, should be recorded, with attention to the presence of associated edema of the penis, scrotum, or legs 9
• Location specificity, including whether the mass is above or below the inguinal ligament, medial versus lateral positioning, and proximity to the pubis, should be noted 11

Critical Risk Factors to Assess

• Previous interventions, such as chemotherapy, radiation therapy, or surgical procedures in the groin or pelvic region, should be documented 9
• Associated symptoms, including obstructive symptoms, fecal incontinence, vaginal involvement, and history of fistula formation, should be assessed 11

Examination of Primary Sites

• A digital rectal examination is mandatory to evaluate for anal lesions and assess perirectal nodal involvement 11
• A vaginal examination in women is necessary to assess for vaginal/vaginal septal involvement, particularly with anteriorly placed masses 11

Common Pitfalls to Avoid

• Up to 50% of palpable inguinal nodes in patients with certain conditions are enlarged due to inflammatory changes rather than malignancy, but 20-25% of clinically node-negative patients harbor occult metastases 10
• Bilateral examination is essential even when the mass appears unilateral due to crossover lymphatic drainage 9

Ultrasound Evaluation and Fine‑Needle Aspiration of Inguinal Lymph Nodes

Requisition Details

• The requisition should document whether inguinal nodes are palpable and describe their size, mobility, and consistency. [NCCN] 12

Clinical Indications for Ultrasound

• Initial staging – Order ultrasound when staging a known primary malignancy that has clinically negative groins. [NCCN] 13
• Evaluation of palpable lymphadenopathy – Use ultrasound to assess palpable inguinal nodes and to guide subsequent fine‑needle aspiration (FNA). [NCCN] 12

When to Add Ultrasound‑Guided FNA

• Simultaneously request ultrasound‑guided FNA if the patient has a known primary malignancy with enlarged inguinal lymph nodes. [Annals of Oncology] 14

Diagnostic Performance of Combined Ultrasound + FNA

• Adding FNA to ultrasound raises the diagnostic yield for metastases larger than 2 mm and provides 91.7 % sensitivity and 98.2 % specificity for detecting malignancy. [NCCN] 13

Epidemiology of Palpable Inguinal Lymphadenopathy

• 30–50 % of palpable inguinal lymph nodes represent inflammatory (benign) processes rather than metastatic disease, underscoring the need for imaging confirmation. [NCCN] 12